IPP Bureau
Dr Mandaviya launches Credit Assistance Program for Jan Aushadhi Kendras
By IPP Bureau - March 13, 2024
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Venus Remedies gets huge global acclaim with UNICEF GMP approval
By IPP Bureau - March 12, 2024
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
Merck completes acquisition of Harpoon Therapeutics
By IPP Bureau - March 12, 2024
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Successful use of Zidebactam/Cefepime to treat skull bone infection & pneumonia caused by extreme-drug resistant pseudomonas
By IPP Bureau - March 12, 2024
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
By IPP Bureau - March 12, 2024
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
USFDA grants orphan drug and pediatric exclusivities for Cresemba for aspergillosis and mucormycosis in children
By IPP Bureau - March 12, 2024
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Pfizer announces positive Phase 3 trial of ADCETRIS regimen in patients with DLBCL
By IPP Bureau - March 12, 2024
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
USFDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
By IPP Bureau - March 12, 2024
It is the first autotaxin inhibitor to be investigated in cancer patients
AbCellera and Biogen collaborate on neurological antibody therapy
By IPP Bureau - March 12, 2024
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
CAPFIMS to provide opportunity for medical graduates and specialists to serve in the medical cadre of CAPFs
By IPP Bureau - March 11, 2024
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Briefs: Zydus Lifesciences and Rainbow Children's Medicare
By IPP Bureau - March 11, 2024
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh
By IPP Bureau - March 11, 2024
The institution will be spread over an area of more than 8 acres
LVPEI observes World Glaucoma Week
By IPP Bureau - March 11, 2024
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Women's integral role in India's US$ 5 trillion ambition
By IPP Bureau - March 11, 2024
Women emerge as the cornerstone of this monumental undertaking
